|
References and Clinical Studies:
Balazs, E.A. and Laurent, T.C., (1998). Round Table Discussion: New Applications
for Hyaluronan, In: Laurent, T.C. (ed.), The Chemistry, Biology and Medical
Applications of Hyaluronan and its Derivatives, pp., Portland Press, London .
Band, P.A., (1998). Hyaluronan Derivatives: Chemical and Clinic Applications,
In: Laurent, T.C. (ed.), The Chemistry, Biology and Medical Applications of
Hyaluronan and its Derivatives, pp. 33–42, Portland Press, London .
Bergamasco, B. and Scarzella, L., Idebenone, a new drug in the treatment of
cognitive impairment in patients with dementia of the Alzheimer type, Funct
Neurol 1994 May-Jun;9(3):161-8.
Danysz, A., Smietanski, J. and Panek, W., The influence of
2-dimethylaminoethanol (DMAE) on the mental and physical efficiency in man. Act
Nerv Super (Praha). 1967 Nov;9(4):417.
Farris, P., Cosmeceuticals: a review of the science behind the claims. Cosmetic
Dermatol. 2003;16(3):59-70.
Fisman, M., Mersky, H. and Helmes, E., Double-blind trial of
2-dimethylaminoethanol in Alzheimer’s disease. Am J Psychiatry. 1981
Jul;138(7):970-2.
Gillis, J.C., Benefield, P. and McTavish, D., Idebenone, a review of its
pharmacodynamic and pharmacokinetic properties, and therapeutic use in
age-related cognitive disorders, Drugs Aging 1994; Aug;5 (2): 133-152.
Gutzmann, H. and Hadler, D., Sustained efficacy and safety of idebenone in the
treatment of Alzheimer's disease: update on a 2-year double-blind multicentre
study, J Neural Transm Suppl 1998;54:301-10.
Ikejiri, Y., Mori, E., Ishii, K., Yasuda, M. and Sasaki, M., Idebenone improves
cerebral mitochondrial oxidative metabolism in a patient with MELAS, Neurology
1996; Aug 47(2); 583-585.
Kligman, A.M., Grove, G..L, Hirose, R. and Leyden, J.J., Topical tretinoin for
photoaged skin. J Am Acad Dermatol 1986;15(4 Pt 2):836-859.
Knudson, C.B. and Knudson, W., (1993). Hyaluronan-binding Proteins in
Development, Tissue Homeostasis, and Disease , FASEB J., 7: 1233–1241.
Laurent, T.C. and Fraser, J.R.E., (1992). Hyaluronan, FASEB J. 6: 2397–2404.
Lerman-Sagie, T., Rustin, P. and Lev, D. Dramatic improvement in mitochondrial
cardiomyopathy following treatment with idebenone, J Inherit Metab Dis 2001
Feb;24(1):28-34.
Pentapeptide offers improvement in human photoaged facial skin. 20th World
Congress of Dermatology (204 subjects - 14 weeks).
Perry, E., Walke,r M., Grace, J. and Perry, R., Acetylcholine in mind: a
neurotransmitter correlate of consciousness? Trends Neurosci. 1999
Jun;22(6):273-80.
Ranen, N.G. and colleagues, A controlled trial of idebenone in Huntington's
disease, Mov Disord 1996 Sep; 11(5):549-554.
Relevance of antiwrinkle treatment of a peptide: 4 months clinical double blind
study vs excipient. 20th World Congress of Dermatology (60 subjects - 4 mos.)
Stein, J. (2002a). WCD: Palmitoyl pentapeptide challenges Retinol as a treatment
for photo-aged skin. July 3: www.pslgroup.com/dg/2177e6.htm.
Stein, J. (2002b). WCD: Palmitoyl pentapeptide improves photo-aged skin.
Uhoda, I., Faska, N., Robert, C., Cauwenbergh, G. and Pierard, G.E., Split face
study on the cutaneous tensile effect of 2-dimethylaminoethanol (deanol) gel.
Skin Res Technol. 2002 Aug;8(3):164-7.
Weyer, G., Babeji-Dolle, R.M., Hadler, D., Hofmann, S. and Herrmann, W.M., A
controlled study of 2 doses of idebenone in the treatment of Alzheimer's
disease, Neuropsychobiology 1997; 36(2):73-82.
Zs-Nagy, I., Pharmacological interventions against aging through the cell plasma
membrane: a review of the experimental results obtained in animals and humans.
Ann N Y Acad Sci. 2002 Apr;959:308-20.
|
